CA2622558A1 - Therapie combinatoire pour une digestion controlee des glucides - Google Patents
Therapie combinatoire pour une digestion controlee des glucides Download PDFInfo
- Publication number
- CA2622558A1 CA2622558A1 CA002622558A CA2622558A CA2622558A1 CA 2622558 A1 CA2622558 A1 CA 2622558A1 CA 002622558 A CA002622558 A CA 002622558A CA 2622558 A CA2622558 A CA 2622558A CA 2622558 A1 CA2622558 A1 CA 2622558A1
- Authority
- CA
- Canada
- Prior art keywords
- agent
- pharmaceutical preparation
- group
- agents
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71753605P | 2005-09-14 | 2005-09-14 | |
US60/717,536 | 2005-09-14 | ||
PCT/US2006/035761 WO2007033292A2 (fr) | 2005-09-14 | 2006-09-13 | Thérapie combinatoire pour une digestion contrôlée des glucides |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2622558A1 true CA2622558A1 (fr) | 2007-03-22 |
Family
ID=37865568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002622558A Abandoned CA2622558A1 (fr) | 2005-09-14 | 2006-09-13 | Therapie combinatoire pour une digestion controlee des glucides |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1931359A4 (fr) |
CN (1) | CN101325959A (fr) |
CA (1) | CA2622558A1 (fr) |
WO (1) | WO2007033292A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7888382B2 (en) | 2005-04-20 | 2011-02-15 | Kissei Pharmaceutical Co., Ltd. | Combined pharmaceutical preparation for treatment of type 2 diabetes |
JP2009514896A (ja) * | 2005-11-07 | 2009-04-09 | エリクシアー ファーマシューティカルズ, インコーポレイテッド | メトホルミンおよびメグリチニドの組み合わせ |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3543999A1 (de) * | 1985-12-13 | 1987-06-19 | Bayer Ag | Hochreine acarbose |
US4898986A (en) * | 1986-09-09 | 1990-02-06 | Takeda Chemical Industries, Ltd. | Inosose derivatives, production and use thereof |
JP2008514549A (ja) * | 2004-09-14 | 2008-05-08 | エリクシアー ファーマシューティカルズ, インコーポレイテッド | 制御された炭水化物消化のための併用療法 |
US20060229261A1 (en) * | 2005-04-12 | 2006-10-12 | John Devane | Acarbose methods and formulations for treating chronic constipation |
-
2006
- 2006-09-13 CA CA002622558A patent/CA2622558A1/fr not_active Abandoned
- 2006-09-13 WO PCT/US2006/035761 patent/WO2007033292A2/fr active Application Filing
- 2006-09-13 EP EP06803558A patent/EP1931359A4/fr not_active Withdrawn
- 2006-09-13 CN CNA2006800425151A patent/CN101325959A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1931359A2 (fr) | 2008-06-18 |
WO2007033292A2 (fr) | 2007-03-22 |
WO2007033292A3 (fr) | 2007-06-28 |
EP1931359A4 (fr) | 2009-04-01 |
CN101325959A (zh) | 2008-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2302702T3 (es) | Composicion farmaceutica que comprende una combinacion de metformina y glibenclamida. | |
JP4845740B2 (ja) | 糖尿病を治療するための組成物および方法 | |
JP6121334B2 (ja) | 胃および結腸製剤ならびにそれらを作製するための方法および使用するための方法 | |
ES2150889T3 (es) | Combinacion de glibenclamida-metformina para el tratamiento de la diabetes mellitus tipo ii. | |
US20060193845A1 (en) | Combination therapy for controlled carbohydrate digestion | |
WO2002004024A1 (fr) | Composition destinee au traitement du diabete | |
RU2201272C2 (ru) | Применение ингибиторов желудочно-кишечной липазы | |
KR20080080220A (ko) | Dpiv 억제제 및 메트포르민 또는 티아졸리딘디온을병용한 2형 당뇨병의 치료 | |
Riddle | Oral pharmacologic management of type 2 diabetes | |
US6916796B2 (en) | Use of pullulan as a slowly digested carbohydrate | |
PT1011673E (pt) | Nova posologia para a dmni | |
KR20080028415A (ko) | PPARγ 애고니스트를 함유하는 의약 조성물 | |
Schlesinger | Methemoglobinemia and anemia in a dog with acetaminophen toxicity. | |
CA2132427A1 (fr) | Methode et composition pour supprimer les effets secondaires des medicaments anti-inflammatoires | |
CA2622558A1 (fr) | Therapie combinatoire pour une digestion controlee des glucides | |
Chan et al. | Short bowel syndrome in adults—part 4-A. A guide to front line drugs used in the treatment of short bowel syndrome | |
AU776376B2 (en) | Remedies for hyperammonemia | |
Hebuterne et al. | Correction of malnutrition following gastrectomy with cyclic enteral nutrition | |
Reasner et al. | Treatment of type 2 diabetes mellitus: a rational approach based on its pathophysiology | |
CN104582701A (zh) | 减轻体重的方法 | |
WO2010093243A1 (fr) | Utilisation d'une combinaison de diazoxyde et de metformine pour le traitement de l'obésité ou des troubles liés à l'obésité | |
US6683098B1 (en) | Use of drug miglitol (Glyset) for treatment of obesity to prevent weight gain for losing weight and for weight control | |
Hoffer | Negative and positive side effects of vitamin B3 | |
Thanikachalam | Review on Comparison of Diabetic Drugs | |
Greenway | Hydrogels in the Treatment of Obesity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |